Concepedia

Publication | Open Access

Evaluation of the safety and immunogenicity of subcutaneous HX575 epoetin alfa in the treatment of anemia associated with chronic kidney disease in predialysis and dialysis patients

DOIFull Paper Access

10

Citations

14

References

2017

Year

Nicole Casadevall, Vladimir Dobronravov, Kai‐Uwe Eckardt, Şehsuvar Ertürk, Liliya Martynyuk, Susanne Schmitt, Gregor Schaffar, Anita Rudy, Andriy Krendyukov, Marité Ode
Clinical Nephrology

Abstract

SC HX575 was effective for correcting and maintaining correction of anemia, and the mean weekly dose remained stable over time. .

References

YearCitations

Page 1